Bushra Zaidi

1.7k total citations · 1 hit paper
18 papers, 1.3k citations indexed

About

Bushra Zaidi is a scholar working on Immunology, Surgery and Oncology. According to data from OpenAlex, Bushra Zaidi has authored 18 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 4 papers in Surgery and 4 papers in Oncology. Recurrent topics in Bushra Zaidi's work include Immunotherapy and Immune Responses (5 papers), CAR-T cell therapy research (3 papers) and Immune Cell Function and Interaction (3 papers). Bushra Zaidi is often cited by papers focused on Immunotherapy and Immune Responses (5 papers), CAR-T cell therapy research (3 papers) and Immune Cell Function and Interaction (3 papers). Bushra Zaidi collaborates with scholars based in United States, Australia and Switzerland. Bushra Zaidi's co-authors include Lucrezia Colonna, José Manuel García‐Verdugo, Violeta Silva-Vargas, Fiona Doetsch, Masoud Tavazoie, Jianda Yuan, Jedd D. Wolchok, Achim A. Jungbluth, Klaus J. Busam and Mary S. Brady and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Bushra Zaidi

18 papers receiving 1.3k citations

Hit Papers

A Specialized Vascular Niche for Adult Neural Stem Cells 2008 2026 2014 2020 2008 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bushra Zaidi United States 10 499 494 274 222 208 18 1.3k
Lucrezia Colonna United States 14 610 1.2× 504 1.0× 736 2.7× 297 1.3× 217 1.0× 23 1.8k
Jadranka Macas Germany 11 824 1.7× 200 0.4× 208 0.8× 162 0.7× 142 0.7× 24 1.4k
Peter J. Darlington Canada 18 447 0.9× 173 0.4× 753 2.7× 215 1.0× 135 0.6× 35 1.6k
Candace L. Kerr United States 27 851 1.7× 191 0.4× 94 0.3× 161 0.7× 176 0.8× 53 1.7k
Lianhua Bai China 21 561 1.1× 437 0.9× 679 2.5× 454 2.0× 292 1.4× 52 2.2k
Christopher Siatskas Australia 20 482 1.0× 160 0.3× 343 1.3× 166 0.7× 129 0.6× 39 1.3k
Andreas Junker Germany 22 759 1.5× 179 0.4× 433 1.6× 241 1.1× 101 0.5× 52 1.9k
Arianna Merlini Italy 12 337 0.7× 194 0.4× 245 0.9× 52 0.2× 151 0.7× 12 945
Manae S. Kurokawa Japan 23 785 1.6× 86 0.2× 361 1.3× 114 0.5× 123 0.6× 82 1.8k
Makoto Migita Japan 19 640 1.3× 113 0.2× 215 0.8× 109 0.5× 129 0.6× 70 1.8k

Countries citing papers authored by Bushra Zaidi

Since Specialization
Citations

This map shows the geographic impact of Bushra Zaidi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bushra Zaidi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bushra Zaidi more than expected).

Fields of papers citing papers by Bushra Zaidi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bushra Zaidi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bushra Zaidi. The network helps show where Bushra Zaidi may publish in the future.

Co-authorship network of co-authors of Bushra Zaidi

This figure shows the co-authorship network connecting the top 25 collaborators of Bushra Zaidi. A scholar is included among the top collaborators of Bushra Zaidi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bushra Zaidi. Bushra Zaidi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Zaidi, Bushra, et al.. (2023). Serum thymidine kinase 1 activity as a prognostic biomarker in dogs with chemotherapy‐treated diffuse large B‐cell lymphoma. Veterinary and Comparative Oncology. 21(2). 200–207. 1 indexed citations
2.
Brightwell, Camille R., Ameya Kulkarni, William Paredes, et al.. (2021). Muscle fibrosis and maladaptation occur progressively in CKD and are rescued by dialysis. JCI Insight. 6(24). 21 indexed citations
3.
Makker, Jasbir, et al.. (2021). Characteristics of Patients with Post-Colonoscopy Unplanned Hospital Visit: A Retrospective Single-Center Observational Study. Clinical and Experimental Gastroenterology. Volume 14. 19–25. 1 indexed citations
4.
Zaidi, Bushra, et al.. (2019). SGLT-2 Inhibition Does Not Improve Left Ventricular Reverse Remodeling in Patients with Diabetes Mellitus Type 2. Journal of Cardiac Failure. 25(8). S12–S12. 4 indexed citations
5.
Zaidi, Bushra, et al.. (2018). A case report of Legionella and Mycoplasma pneumonia. Medicine. 97(40). e12650–e12650. 2 indexed citations
6.
Abbas, Hafsa, et al.. (2018). Charlson Comorbidity Index (CCI): An Independent Predictor of Outcomes in Clostridium difficile Infection (CDI). The American Journal of Gastroenterology. 113(Supplement). S1525–S1525. 4 indexed citations
7.
Abramowitz, Matthew K., William Paredes, Kehao Zhang, et al.. (2018). Skeletal muscle fibrosis is associated with decreased muscle inflammation and weakness in patients with chronic kidney disease. American Journal of Physiology-Renal Physiology. 315(6). F1658–F1669. 48 indexed citations
8.
Hohenhaus, Ann E., et al.. (2016). Retrospective evaluation of toceranib phosphate (Palladia) in cats with oral squamous cell carcinoma. Journal of Feline Medicine and Surgery. 19(2). 185–193. 30 indexed citations
9.
Gyorki, David, Jianda Yuan, Zhenyu Mu, et al.. (2013). Immunological Insights from Patients Undergoing Surgery on Ipilimumab for Metastatic Melanoma. Annals of Surgical Oncology. 20(9). 3106–3111. 42 indexed citations
10.
Gyorki, David, Jianda Yuan, Zhenyu Mu, et al.. (2012). Surgery for patients receiving ipilimumab: Safety profile and immunological insights.. Journal of Clinical Oncology. 30(15_suppl). 8583–8583. 1 indexed citations
11.
Perales, Miguel‐Angel, Jeffrey L. Goldberg, Jianda Yuan, et al.. (2012). Recombinant human interleukin-7 (CYT107) promotes T-cell recovery after allogeneic stem cell transplantation. Blood. 120(24). 4882–4891. 140 indexed citations
12.
Wahlstrom, Justin T., Aimee M. Beaulieu, Bushra Zaidi, et al.. (2011). Altered Development of NKT Cells, γδ T Cells, CD8 T Cells and NK Cells in a PLZF Deficient Patient. PLoS ONE. 6(9). e24441–e24441. 46 indexed citations
13.
Perales, Miguel‐Angel, Jeffrey L. Goldberg, Jianda Yuan, et al.. (2011). Recombinant Human Interleukin-7 (CYT107) Promotes T Cell Recovery Following T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantion. Biology of Blood and Marrow Transplantation. 17(2). S234–S234. 1 indexed citations
14.
15.
Amin, Bijal, Kishwer S. Nehal, Achim A. Jungbluth, et al.. (2008). Histologic Distinction Between Subungual Lentigo and Melanoma. The American Journal of Surgical Pathology. 32(6). 835–843. 63 indexed citations
16.
Tavazoie, Masoud, Violeta Silva-Vargas, Lucrezia Colonna, et al.. (2008). A Specialized Vascular Niche for Adult Neural Stem Cells. Cell stem cell. 3(3). 279–288. 805 indexed citations breakdown →
17.
Jungbluth, Achim A., Wilson A. Silva, Kristin Iversen, et al.. (2007). Expression of cancer-testis (CT) antigens in placenta.. PubMed. 7. 15–15. 62 indexed citations
18.
Johnston, Dean, Bushra Zaidi, & Jean‐Claude Bystryn. (2006). TLR7 imidazoquinoline ligand 3M-019 is a potent adjuvant for pure protein prototype vaccines. Cancer Immunology Immunotherapy. 56(8). 1133–1141. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026